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Abstract 
Background: Allergic rhinitis (AR) is a common disease affecting 5–45% of Asian population. Although it 
is not a life-threatening disease, AR significantly hampers the quality of life of the sufferers. The prevalence 
of AR among adults in Indonesia is still unknown. This study aimed to measure the prevalence of AR among batch 2010 students of the Faculty of Medicine, Universitas Padjadjaran.
Methods: A cross-sectional study was conducted during June–October 2013 involving Indonesian class 
batch 2010 students of the Faculty of Medicine, Universitas Padjadjaran. The sampling was performed using 
total sampling approach. The measurement tool used in this study was the Indonesian translation of the 
Allergic Rhinitis and its Impact on Asthma-World Health Organization (ARIA-WHO) questionnairee. Those 
who were aware of being diagnosed with AR or had two/more AR defining symptoms in the questionnaire 
form were considered to have AR. The statistical analysis was conducted by calculating frequencies.
Results: A total of 207 questionnaire forms were adequately filled out and returned. Based on the 
questionnaire, the prevalence rate of AR was 38.2%. Of the 79 AR cases, 66% cases involved females. In addition, 54% of the the AR cases have a parental history of allergic diseases. Nasal obstruction and itchy 
nose were the most frequent symptoms (90%), followed by rhinorrhea (89%), sneezing (82%), and eye 
symptoms (62%). Based on the duration, the majority fell into the intermittent group (91%); whereas based on severity, the majority was in the moderate-severe group (71%).
Conclusions: The prevalence rate of AR obtained in this study is within the estimated range of Asian population. [AMJ.2015;2(4):620–5]
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IntroductionAllergic rhinitis (AR) is a common disease 
defined as a symptomatic disorder of the nose 
resulting from IgE-mediated inflammation of the nasal membranes after allergen exposure.1 
Frequent allergens include pollens, moulds, 
animal dander, and dust mites. The AR is characterized by rhinorrhea (watery runny nose), sneezing (especially violent and in bouts), nasal obstruction, itchy nose, and usually associated with eye symptoms.1,2
The AR can be diagnosed in several steps, consisting of anamnesis, physical examination, and supporting examination. Allergic Rhinitis 
and its Impact on Asthma-World Health Organization (ARIA-WHO) has developed a 
questionnaire as a screening tool for AR.1 Due to its good validity and high sensitivity, ARIA-
WHO questionnaire has been used widely for many studies related to AR.3 Those with the abovementioned classical symptoms of AR are most likely to be allergic. Physical examination can reveal the outward signs of allergy (e.g. allergic crease, allergic shiners, etc) and structural abnormality of the nasal cavities. Furthermore, supporting examinations may 
include skin-prick test and/or serum-specific 
IgE, which can confirm the diagnosis of AR.1
The common symptoms of AR often disrupt 
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quality of life including the sleep pattern which may further cause exhaustion, drowsiness, emotional instability, and diminution of 
performance at the workplace. The AR also has a negative impact on productivity and socioeconomic conditions. According to a 
survey in the United States, 55% of 8,267 workers stated that AR symptoms had made them unproductive for 3.6 days per year.4 World Allergy Organization (WAO) reported that in the United States alone, the indirect 
financial loss related to low productivity 
reached up to $9.7 billion in 2005, whereas 
the direct financial loss for expenditure on medications and health care provision reached $11.2 billion.2
The AR patients may develop other comorbidities, some of which include asthma, allergic conjunctivitis, and rhinosinusitis. 
The comorbidities have always been closely linked with AR, for there are histological and immunological similarities between the upper 
and lower respiratory tracts. The comorbidities can even be more severe that the disorder and may directly have an unfavorable impact on 
the quality of life.5  Epidemiologically, AR affects 10–30% of world population and the prevalence is still increasing.2 According to the 2008 World Allergy Report6, the prevalence of AR in the low and middle income countries within Asia-
Pacific Region was estimated to be around 5–45%. Unfortunately, the prevalence rate among adults in Indonesia is still unknown. Meanwhile, it is shown that 64.6% of AR patients who visited the Department of Otolaryngology-Head & Neck Surgery, Dr. Hasan Sadikin General Hospital Bandung 
were between 10 to 29 years old, a relatively productive age group. Besides, it is also found that, based on occupation, 45.1% of the patients were students.7In line with the above explanation, AR is a prevalent devastating disorder that affects 
primarily young adults. The objective of this study was to measure the prevalence of AR among batch 2010 students of the Faculty of Medicine, Universitas Padjadjaran.
Methods
This study was conducted during June–October 2013 using the cross-sectional 
method as the study design. The ARIA-WHO 
questionnaire that had been translated into Indonesian language by an authorized and sworn translator from LIA Language 
Center and Vocational Training (LBPP LIA) 
was used. The population of this study was obtained from batch 2010 students of regular class of the Faculty of Medicine Universitas, 
Padjadjaran. The sampling was total sampling. 
There were thus a total of 207 respondents invited to participate as the subjects in this study. Moreover, ethical clearance of this study was released by the Health Research Ethics Committee of the Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung.
All 207 respondents were asked to fill out 
the ARIA-WHO questionnaire forms. Informed 
consent was obtained from all participants. The 
questionnaires were then screened and those 
who answered yes to any of the AR defining 
symptoms were shortlisted. Those who were aware of being diagnosed with AR or those 
who had two/more AR defining symptoms (rhinorrhea, sneezing, nasal obstruction, and itchy nose) were considered to have AR.
     The screened AR cases were subsequently 
classified based on some commonly observed characteristics including sex, parental history, 
symptoms, and ARIA-WHO classifications. Eventually, the statistical analysis was 
performed by calculating frequencies. 
Results 
All 207 respondents in this study filled out the 
questionnaire forms adequately. This study revealed that the prevalence of AR among 
respondents were 79 out of 207 respondents 
(38.2%), of which more than 60% cases involved  female respondents. In addition, more than half of the AR cases have a parental 
history of allergic diseases (Table 1).
The AR cases were then classified according to the symptoms that they have or a history of 
suffering the disease. They might have chosen one or more symptoms provided in the ARIA-
WHO questionnaire forms. This study revealed 
that the most frequent symptoms were nasal obstruction and itchy nose, followed by rhinorrhea, sneezing, and eye symptoms 
(Table 2).Furthermore, the prevalence of AR among respondents was categorized according 
to ARIA-WHO classification. Based on the duration of the symptoms, the AR cases were divided into intermittent and persistent 
groups; whereas based on the quality of life hampered, they were divided into mild and 
moderate-severe groups. This study revealed 
that the majority of the cases were classified as intermittent based on the duration of the symptoms and moderate-severe based on the 
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quality of life hampered (Table 3).
Discussion It was found that the prevalence rate of allergic rhinitis (AR) among respondents in 
this study was 38.2%, which is within the estimated range for Asian population. World 
Allergy Report 2008 reported that in many parts of Asia, especially in low- and middle-income countries, the prevalence rate of AR has increased from 5% to 45% as the society is being modernized.6 However, it was found that the actual number varied between countries. For example in the Philippines, the overall prevalence of AR among adults based on the 
2008 National Nutrition and Health Survey was 20.0%.8 Another study conducted in Jaipur City, India showed that the prevalence of AR among school-children there was 33.5%.9 Meanwhile, the result obtained in this study was actually slightly higher than the estimated range of the 
global population. The WAO reported that AR is a common disease affecting an estimate of 10–30% population globally.2 Until recently, the prevalence rate of AR among adults in Indonesia is still unknown. In 
Bandung, however, there were 7% perennial AR cases in the age group of more than 10 years old.10 The discrepancy of the result obtained in the current study compared to the global estimate can be due to the study design used. 
This study was a questionnaire only-based 
survey. The ARIA-WHO questionnaire has actually been widely used as a screening test for AR in many studies due to its high sensitivity. A study conducted in Korea concluded that 
the questionnaire showed better validity compared to the conventional ones.3 However, 
it was found that the specificity of the 
questionnaire was not really high, so there might be many false positives included in the results.11 Thorough examinations comprising physical examination and diagnostic testing would yield a better and more accurate result.1 Another result of this study was the fact that the prevalence of AR among female respondents and male respondents was 66% 
and 34%, respectively. This is relevant to a study done by Asha’ari et al.12 who found that 61.1% of newly-diagnosed AR cases in Malaysia involve female patients. Likewise, some studies conducted in Dr. Hasan Sadikin General Hospital Bandung also present similar 
Table 1 Characteristics of Respondents
Characteristics Allergic Rhinitis 
(n=79)
Non Allergic Rhinitis 
(n=128)Sex     Male 27 (34%) 50 (39.1%)     Female 52 (66%) 78 (60.9%)Parental history     Mother or father 34 (43%) 14 (10.9%)     Both parents 9 (11%) 2 (1.6%)     No history 36 (46%) 112 (87.5%)
Total 79 (38.2%) 128 (61.8%)
Table 2 Frequency of the Identifiable Symptoms
Identifiable symptoms Number of respondents (percentage)Nasal obstruction* 71/79 (90%)Itchy nose 71/79 (90%)Rhinorrhea** 70/79 (89%)Sneezing# 65/79 (82%)Eye symptoms## 49/79 (62%)
Note: The respondents may have chosen more than 1 symptom provided in the ARIA-WHO questionnaire. *Feeling of             being unable to breathe through nose **Watery, runny nose #Violent and in bouts ##Watery, red itchy eyes
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findings, Sudiro13 found that 55.3% of the AR cases involved female and, one year later, Syukrie7 found 61.0% also involved female patients. Moreover, 60.3% of AR cases detected 
among citizens in Taif, Saudi Arabia14 involved females as well. Hence, the high proportion of AR cases among women should be analyzed further to assess whether they are more 
prone to have AR compared to men. The result showing more female cases in this study could be due to the disproportionate distribution 
of the subjects. A total of 130 (62.8%) female subjects out of the 207 respondents were invited to participate in this study, so the result in this study could have been exaggeratedly reported in this regard. In the present study, more than half of the AR cases have a parental history of allergic diseases, such as asthma, atopic dermatitis, or AR itself. A Western Europe-based survey 
in 2004 showed that there were 68.1% of AR diagnosed patients who reported of having a family history of any allergic conditions.15 Asha’ari et al.12 also found that 54.4% of AR patients in Malaysia had a family history of allergic diseases. Meanwhile, Syukrie7 found that 50.4% of AR patients in Dr. Hasan Sadikin General Hospital Bandung also had a positive family history. It has long been known that the genetic background is one of the most important factors for developing any allergic diseases.1 A child with one atopic parent would possess a 30% risk of having allergic diseases, whereas a child with both atopic parents would possess an additional 20% risk.16 Furthermore, a study conducted by 
Tamay et al.17 in Istambul, Turkey showed that a child with a positive family history carried a greater risk for developing AR. 
The present study applied the ARIA-WHO 
guidelines to define the diagnostic criteria for AR, which are characterized by having two or more nasal symptoms.9 Other conditions that can be presence include eye symptoms. 
The ARIA-WHO questionnaire makes it possible for the respondents to choose more than one symptom that they have or have a history of suffering from. Long18 conducted a survey on 1,000 AR patients and found that the 
majority experienced nasal obstruction (85%), followed by sneezing (63%), eye itchiness (60%), rhinorrhea (56%), watery eyes (51%) 
and nasal itchiness (41%). Saini,9 on the other 
hand, found that the most frequent symptom 
was nasal obstruction (48.6%), followed by rhinorrhea (33.0%), sneezing (24.1%), and itchy nose (20.3%). Another study conducted in Boshroye, Iran19 found that rhinorrhea was the most prevalent symptom among atopic group (33%), followed by sneezing (33%), 
nasal obstruction (28.8%), itchy nose and eyes 
(18.0%), and other eye symptoms. In the present study, however, it was revealed that nasal obstruction and itchy nose were the 
highest presenting symptoms (90%), followed 
by rhinorrhea (90%), sneezing (82%), and eye 
symptoms (62%). The discrepancy of each study is most likely due to common variations of symptoms within AR patients.
The ARIA-WHO guidelines were also used 
as the classification system based on the 
duration of the symptoms and the quality of life hampered.1 The majority of the AR cases in some of the previous studies fell into persistent group.7,12 Interestingly, more than 
90% of the AR cases in the present study were in the intermittent group, similar to a study carried out in Jaipur City, India,9 although in a 
much lower percentage. This contrast is most likely due to the different subjects involved 
Table 3 Prevalence of Allergic Rhinitis based on ARIA-WHO Classification 
Classification Number of cases (percentage)Based on duration     Intermittent* 72 (91%)     Persistent** 7 (9%)
Based on quality of life hampered     Mild# 23 (29%)     Moderate-severe## 56 (71%)
Total 79 (100%)
Note: *Intermittent: <4 days/week or <4 consecutive weeks **Persistent: >4 days/week or >4 consecutive weeks #Mild:             Normal sleep and no impairment of daily activities, normal work or school, no troublesome symptoms ## 
            Moderate-severe: One or more: abnormal sleep, impairment of daily activities, abnormal work or school,             troublesome symptoms.
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in each study. The aforementioned studies involved AR patients who came to the hospital, and there would be a high possibility that they had persistent symptoms so they needed 
immediate medical interventions. This could 
also be due to the inconsistency in filling out 
the questionnaire form. The respondents might not be aware that the symptoms they encountered were in fact more long-lasting.
Based on the quality of life hampered, the majority of the AR cases fell into the moderate-severe group, which is similar to most studies.7,9,12 Moderate-severe is characterized by several conditions such as abnormal sleep, impairment of daily activities, abnormal work/school, or troublesome symptoms.1 The respondents who participated in this study were students who stay mostly in Bandung and nearby areas, in which the weather and humidity are suitable for the growth and development of dust mites, commonly Dermatophagoides pteronyssinus (Der p).1 
Therefore, it is probable that the subjects 
have been frequently exposed to the dust mite species. Furthermore, the subjects involved in this study were all students and relatively do not have time to do sports or exercises and thus increases the risk to hamper their 
quality of life. It is known that doing a regular 
exercise could balance the type 1 and type 2 T 
helper cells (also known as Th1 and Th2 cells, respectively) so the hypersensitivity effect would be less severe.20 In conclusion, the prevalence rate obtained in the present study is within the estimated range of Asian population. Some of the characteristics of the AR cases, including sex, 
parental history, and ARIA-WHO classification were also considered to be relevant to most 
studies. Since this was a questionnaire only-based survey, further studies that include thorough examinations including physical examination and diagnostic testing would yield a better result on this matter. 
References1. Bousquet J, Khaltaev N, Cruz AA, Denburg 
J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 
2008 update (in collaboration with the World Health Organization, GA(2)LEN and 
AllerGen). Allergy. 2008;63(S86):8–160. 2. Pawankar R, Canonica GW, Holgate 
ST, Lockey RF, editors. World Allergy Organization (WAO) White Book on 
Allergy 2011–2012: executive summary. 
Milwaukee: WAO; 2011.
3. Chung YJ, Cho IK, Lee KI, Bae SH, Lee 
JW, Chung PS, et al. Seasonal specificity of seasonal allergens and validation of 
the ARIA classification in Korea. Allergy 
Asthma Immunol Res. 2013;5(2):75–80.4. Camelo-Nunes IC, Sole D. Allergic rhinitis: 
indicators of quality of life. J Bras Pneumol. 
2010;36(1):124–33.5. Meltzer EO, Szwarcberg J, Pill MW. Allergic 
rhinitis, asthma, and rhinosinusitis: diseases of the integrated airway. J Manag 
Care Pharm. 2004;10(4):310–7.6. Pawankar R, Baena-Cagnani CE, Bousquet J, Canonica GW, Cruz AA, Kaliner MA, et al. 
State of world allergy report 2008: allergy and chronic respiratory diseases. World 
Allergy Organ J. 2008;1(6 Suppl):4–17.7. Syukrie A. Hubungan antara klasifikasi 
ARIA-WHO 2008 dengan hasil tes kulit tusuk pada penderita rinitis alergi yang 
berobat di Bagian Ilmu Kesehatan THT-
KL RSHS/FK Unpad Periode 2010 [thesis]. 
Bandung: Universitas Padjadjaran; 2011.
8. Abong JM, Kwong SL, Alava HD, Castor MA, De Leon JC. Prevalence of allergic rhinitis in Filipino adults based on the National 
Nutrition and Health Survey 2008. Asia 
Pac Allergy. 2012;2:129–35.
9. Saini A, Gupta M, Sharma BS, Kakkar M, Chaturvedy G. Rhinitis, sinusitis and 
ocular disease–2085. Prevalence of allergic rhinitis in urban school children, Jaipur City, India. World Allergy Organ J. 
2013;6(Suppl 1):164.10. Sudiro M, Madiadipoera TH, Purwanto 
B. Eosinofil kerokan mukosa hidung sebagai diagnostik rinitis alergi. MKB. 
2010;42(1):6–11.11. Hojo M, Ohta K, Iikura M, Mizutani 
T, Hirashima J, Sugiyama H. Clinical usefulness of a guideline-based screening tool for the diagnosis of allergic rhinitis 
in asthmatics: the self assessment of 
allergic rhinitis and asthma questionnaire. 
Respirology. 2013;18(6):1016–21.12. Asha’ari ZA, Yusof S, Ismail R, Che Hussin CM. Clinical features of allergic rhinitis and skin prick test analysis based on the 
ARIA classification: a preliminary study in Malaysia. Ann Acad Med Singapore. 
2010;39(8):619–24.13. Sudiro M. Karakteristik penderita rinitis 
alergi di Bagian I. Kes THT-KL RS Dr. Hasan 
Sadikin Bandung/FK UNPAD Tahun 2007-
2009. Proceeding of Kongres Nasional 
PERHATI-KL XV; 2010 Jul 7–9; Makassar. 
Makassar: Balai Penerbitan Universitas 
Hasanuddin; 2010.
Althea Medical Journal. 2015;2(4)
625
14. Sabry EY. Prevalence of allergic diseases 
in a sample of Taif citizens assessed by an 
original Arabic questionnaire (phase I) A pioneer study in Saudi Arabia. Allergol 
Immunopathol (Madr). 2011;39(2):96–105.15. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in 
Europe. Eur Respi J. 2004;24(5):758–64.16. Male DK, Brostoff J, Roth DB. Immunology. 
8th ed. Philadelphia: Saunders Elsevier; 2006.17. Tamay Z, Akcay A, Ones U, Guler N, Kilic G, Zencir M. Prevalence and risk factors for allergic rhinitis in primary school children. Int J Pediatr Otorhinolaryngol. 
2007;71(3):463–71.
18. Long AA. Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on 
individuals with allergic rhinitis. Clin Ther. 
2007;29(2):342–51.
19. Fereidouni M, Abolhasani A, Vahedi F, 
Shakeri MT, Varasteh A. A preliminary survey of the prevalence of allergic 
disorders in a questionnaire-based study in Boshroye, a rural area of Iran. J Public 
Health. 2010;18(2):119–21.20. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for 
health and disease. Altern Med Rev. 2003; 
8(3):223–46.
Fauzi, Melati Sudiro, Bony Wiem Lestari: Prevalence of Allergic Rhinitis based on World Health Organization (ARIA-WHO) 
questionnaire among Batch 2010 Students of the Faculty of Medicine Universitas Padjadjaran
